Cargando…
Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial
INTRODUCTION: Docosahexaenoic acid (DHA) is an omega-3 (n-3) fatty acid that accumulates into neural tissue during the last trimester of pregnancy, as the fetal brain is undergoing a growth spurt. Infants born <29 weeks’ gestation are deprived the normal in utero supply of DHA during this period...
Autores principales: | Gould, Jacqueline F, Makrides, Maria, Sullivan, Thomas R, Anderson, Peter J, Gibson, Robert A, Best, Karen P, McPhee, Andrew J, Doyle, Lex William, Opie, Gillian, Travadi, Javeed, Cheong, Jeanie, Davis, Peter G, Sharp, Mary, Simmer, Karen, Collins, Carmel T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925903/ https://www.ncbi.nlm.nih.gov/pubmed/33550243 http://dx.doi.org/10.1136/bmjopen-2020-041597 |
Ejemplares similares
-
Protocol for assessing if behavioural functioning of infants born <29 weeks’ gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023) -
Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
por: Collins, Carmel T, et al.
Publicado: (2015) -
Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2018) -
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016)